India
# |
Name |
Receivables |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 1.35 B
|
March 31, 2024 | USD 20.10 | 0.21% |
|
India |
|
2 |
USD 962.69 M
|
March 31, 2024 | USD 14.03 | 1.84% |
|
India |
|
3 |
USD 746.99 M
|
March 31, 2024 | USD 4.18 | 1.48% |
|
India |
|
4 |
USD 668.60 M
|
March 31, 2024 | USD 11.18 | 1.69% |
|
India |
|
5 |
USD 577.48 M
|
March 31, 2024 | USD 13.51 | -1.02% |
|
India |
|
6 |
USD 571.95 M
|
March 31, 2024 | USD 17.05 | 1.44% |
|
India |
|
7 |
USD 376.38 M
|
March 31, 2024 | USD 7.17 | 1.17% |
|
India |
|
8 |
USD 319.00 M
|
March 31, 2024 | USD 78.50 | -0.28% |
|
India |
|
9 |
USD 274.00 M
|
March 31, 2024 | USD 58.36 | 0.18% |
|
India |
|
10 |
USD 255.94 M
|
March 31, 2024 | USD 2.68 | 0.64% |
|
India |
|
11 |
USD 250.45 M
|
March 31, 2024 | USD 64.29 | -2.83% |
|
India |
|
12 |
USD 222.81 M
|
March 31, 2024 | USD 16.75 | 0.23% |
|
India |
|
13 |
USD 221.11 M
|
March 31, 2024 | USD 37.68 | -1.96% |
|
India |
|
14 |
USD 203.24 M
|
March 31, 2024 | USD 6.73 | -0.82% |
|
India |
|
15 |
USD 203.17 M
|
March 31, 2024 | USD 16.64 | -0.86% |
|
India |
|
16 |
USD 197.60 M
|
March 31, 2024 | USD 17.57 | 1.15% |
|
India |
|
17 |
USD 149.48 M
|
March 31, 2024 | USD 31.06 | 0.59% |
|
India |
|
18 |
USD 142.54 M
|
March 31, 2024 | USD 13.53 | 0.96% |
|
India |
|
19 |
USD 136.90 M
|
March 31, 2024 | USD 7.90 | 4.00% |
|
India |
|
20 |
USD 122.87 M
|
March 31, 2024 | USD 10.61 | 0.92% |
|
India |
|
21 |
USD 121.50 M
|
March 31, 2024 | USD 11.23 | 1.68% |
|
India |
|
22 |
USD 115.11 M
|
March 31, 2024 | USD 58.97 | 0.20% |
|
India |
|
23 |
USD 101.70 M
|
March 31, 2024 | USD 28.07 | -2.08% |
|
India |
|
24 |
USD 99.07 M
|
March 31, 2024 | USD 5.13 | 1.46% |
|
India |
|
25 |
USD 84.47 M
|
March 31, 2024 | USD 4.67 | -0.69% |
|
India |
|
26 |
USD 84.44 M
|
March 31, 2024 | USD 20.33 | 0.95% |
|
India |
|
27 |
USD 77.69 M
|
March 31, 2024 | USD 6.91 | -0.24% |
|
India |
|
28 |
USD 76.83 M
|
March 31, 2024 | USD 7.38 | -1.23% |
|
India |
|
29 |
USD 74.09 M
|
March 31, 2024 | USD 16.33 | 9.92% |
|
India |
|
30 |
USD 73.18 M
|
March 31, 2024 | USD 8.15 | -0.17% |
|
India |
|
31 |
USD 62.26 M
|
March 31, 2024 | USD 6.74 | -0.47% |
|
India |
|
32 |
USD 59.54 M
|
March 31, 2024 | USD 12.23 | 1.60% |
|
India |
|
33 |
USD 57.47 M
|
March 31, 2024 | USD 15.99 | 6.29% |
|
India |
|
34 |
USD 56.50 M
|
March 31, 2024 | USD 4.15 | 0.28% |
|
India |
|
35 |
USD 55.41 M
|
March 31, 2024 | USD 8.61 | -1.79% |
|
India |
|
36 |
USD 55.22 M
|
March 31, 2024 | USD 301.67 | 0.10% |
|
India |
|
37 |
USD 54.33 M
|
March 31, 2024 | USD 2.78 | 0.16% |
|
India |
|
38 |
USD 50.60 M
|
March 31, 2024 | USD 14.15 | 2.83% |
|
India |
|
39 |
USD 47.00 M
|
March 31, 2024 | USD 8.18 | 0.56% |
|
India |
|
40 |
USD 45.46 M
|
March 31, 2024 | USD 0.39 | 4.91% |
|
India |
|
41 |
USD 45.08 M
|
March 31, 2024 | USD 162.79 | 2.84% |
|
India |
|
42 |
USD 41.78 M
|
March 31, 2024 | USD 5.91 | 3.15% |
|
India |
|
43 |
USD 38.96 M
|
March 31, 2024 | USD 0.75 | 4.08% |
|
India |
|
44 |
USD 38.41 M
|
March 31, 2024 | USD 7.02 | 1.27% |
|
India |
|
45 |
USD 35.25 M
|
March 31, 2024 | USD 5.90 | -0.62% |
|
India |
|
46 |
USD 34.59 M
|
March 31, 2024 | USD 11.58 | 3.63% |
|
India |
|
47 |
USD 32.36 M
|
March 31, 2024 | USD 26.86 | 1.04% |
|
India |
|
48 |
USD 28.70 M
|
March 31, 2024 | USD 1.91 | 6.74% |
|
India |
|
49 |
USD 28.32 M
|
March 31, 2024 | USD 2.33 | 0.83% |
|
India |
|
50 |
USD 28.31 M
|
March 31, 2024 | USD 11.98 | -1.00% |
|
India |
The Healthcare company in India with the highest Receivables is Sun Pharmaceutical Industries Limited (NSE: SUNPHARMA.NS) at USD 1.35 B.
The Healthcare company in India with the lowest Receivables is Lupin Limited (NSE: LUPIN.NS) at USD 0.00.
The top 10 Healthcare companies in India by Receivables are Sun Pharmaceutical Industries Limited, Dr. Reddy's Laboratories Limited, Biocon Limited, Zydus Lifesciences Limited, Aurobindo Pharma Limited, Cipla Limited, Hinduja Global Solutions Limited, Apollo Hospitals Enterprise Limited, Alkem Laboratories Limited and Piramal Pharma Limited.
The bottom 10 Healthcare companies in India by Receivables are Lupin Limited, Thyrocare Technologies Limited, Granules India Limited, Piramal Enterprises Limited, Jagsonpal Pharmaceuticals Limited, TAKE Solutions Limited, GFL Limited, Suven Life Sciences Limited, Krebs Biochemicals & Industries Limited and Max India Limited.